Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1998-06-05
2000-10-31
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, 5142362, 514310, 514324, 514428, 514448, 514470, 514565, A61K 3156, A61K 31535
Patent
active
061403156
ABSTRACT:
A method of decreasing atherosclerosis and its complications, such as myocardial infarction, stroke and peripheral vascular disease, wherein the method involves administering to a human or an animal an amount of goserelin acetate sufficient to decrease atherosclerosis and its complications.
REFERENCES:
patent: 5770609 (1998-06-01), Grainger et al.
patent: 5872114 (1999-02-01), Labrie
patent: 5906987 (1999-04-01), Chwalisz et al.
Goodman and Gilman's Pharmacological Basis of Therapeutics, pp. 1427-1429, 1980.
Goldberg Michael
Weisman Kenneth M.
Owens Howard
Wilson James O.
LandOfFree
Therapeutic uses of goserelin acetate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic uses of goserelin acetate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of goserelin acetate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2051929